Skip to main content
. Author manuscript; available in PMC: 2019 Apr 19.
Published in final edited form as: Clin Pharmacol Biopharm. 2017 May 18;6:170. doi: 10.4172/2167-065X.1000170

Figure 2:

Figure 2:

Variation of plasma level of oxidised-LDL during treatment with the two nutraceuticals formulas. *p<0.001 vs. baseline values; **p<0.01 vs. FPP-treated group.